Image

TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma

Study of TR-002 for Advanced Solid Tumors and Refractory Pancreatic Adenocarcinoma

Recruiting
18 years and older
All
Phase 1
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the treatment of advanced solid tumors and pancreatic adenocarcinoma that cannot be removed by surgery. The purpose of this study is to evaluate the safety and best dose of an investigational medication for these conditions.

The study evaluates the safety and side effects of the investigational medication. It also looks at how the medication affects the body and its potential effectiveness in treating the conditions.

  • Who can participate: Adults aged 18 and over with advanced solid tumors or refractory pancreatic adenocarcinoma may be eligible. Participants must have tumors that are not responding to standard treatments.
  • Study details: Participants will receive the investigational medication through an IV. Some participants may receive a placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine.
Print
Study details
    Advanced Malignant Solid Neoplasm
    Metastatic Malignant Solid Neoplasm
    Metastatic Pancreatic Adenocarcinoma
    Refractory Pancreatic Adenocarcinoma
    Stage III Pancreatic Cancer AJCC v8
    Stage IV Pancreatic Cancer AJCC v8
    Unresectable Malignant Solid Neoplasm
    Unresectable Pancreatic Adenocarcinoma

NCT07189195

University of California, Davis

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.